• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脉络膜增厚谱系疾病的统一分类]

[Uniform classification of the pachychoroid spectrum disorders].

作者信息

Abdin Alaa Din, Suffo Shady, Fries Fabian N, Kaymak Hakan, Seitz Berthold

机构信息

Klinik für Augenheilkunde, Universitätsklinikum des Saarlandes UKS, Kirrberger Str. 100, Gebäude 22, 66421, Homburg/Saar, Deutschland.

Internationale Innovative Ophthalmochirurgie (I. I. O.), 40549, Düsseldorf, Deutschland.

出版信息

Ophthalmologe. 2021 Aug;118(8):865-878. doi: 10.1007/s00347-021-01379-4. Epub 2021 Apr 26.

DOI:10.1007/s00347-021-01379-4
PMID:33900429
Abstract

Pachychoroid spectrum disorders are characterized by a thickening of the choroid. The spectrum includes pachychoroid pigment epitheliopathy (PPE), central serous chorioretinopathy (CCS), pachychoroid neovasculopathy (PNV), polypoidal choroidal vasculopathy (PCV)/aneurysmal type 1 choroidal neovascularization (ACNV-1), focal choroidal excavation (FCE) and peripapillary pachychoroid syndrome (PPS). If the choroid is thickened and there is a pathological alteration in the retinal pigment epithelium, the diagnosis is PPE; if the thickened choroid is accompanied by subretinal fluid, the diagnosis is CCS; if choroidal neovascularization is present, the diagnosis is PNV; if accompanied by aneurysms, the diagnosis is ACNV‑1. The PPE, CCS, PNV and ACNV‑1 were formerly regarded as independent disease entities but can be classified into four forms of a single disease family, pachychoroid macular disease.

摘要

厚脉络膜谱系疾病的特征是脉络膜增厚。该谱系包括厚脉络膜色素上皮病变(PPE)、中心性浆液性脉络膜视网膜病变(CCS)、厚脉络膜新生血管病变(PNV)、息肉样脉络膜血管病变(PCV)/1型动脉瘤样脉络膜新生血管(ACNV-1)、局限性脉络膜凹陷(FCE)和视盘周围厚脉络膜综合征(PPS)。如果脉络膜增厚且视网膜色素上皮存在病理改变,则诊断为PPE;如果增厚的脉络膜伴有视网膜下液,则诊断为CCS;如果存在脉络膜新生血管,则诊断为PNV;如果伴有动脉瘤,则诊断为ACNV-1。PPE、CCS、PNV和ACNV-1以前被视为独立的疾病实体,但可归类为单一疾病家族的四种形式,即厚脉络膜黄斑疾病。

相似文献

1
[Uniform classification of the pachychoroid spectrum disorders].[脉络膜增厚谱系疾病的统一分类]
Ophthalmologe. 2021 Aug;118(8):865-878. doi: 10.1007/s00347-021-01379-4. Epub 2021 Apr 26.
2
Pachychoroid disease spectrum: review article.脉络膜增厚疾病谱:综述文章。
Graefes Arch Clin Exp Ophthalmol. 2022 Mar;260(3):723-735. doi: 10.1007/s00417-021-05450-3. Epub 2021 Oct 14.
3
Pachychoroid spectrum disease.厚脉络膜谱系疾病
Acta Ophthalmol. 2021 Sep;99(6):e806-e822. doi: 10.1111/aos.14683. Epub 2020 Nov 30.
4
EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY.使用扫频光学相干断层扫描对厚脉络膜疾病谱进行正面成像
Retina. 2016 Mar;36(3):499-516. doi: 10.1097/IAE.0000000000000742.
5
Pachychoroid neovasculopathy.厚脉络膜新生血管病变
Retina. 2015 Jan;35(1):1-9. doi: 10.1097/IAE.0000000000000331.
6
[Pachychoroid Disease].[厚脉络膜疾病]
Klin Monbl Augenheilkd. 2023 Feb;240(2):218-232. doi: 10.1055/a-1967-2522. Epub 2022 Nov 17.
7
A comparative study on the choroidal vascularity index and the determination of cut-off values in the pachychoroid spectrum diseases.脉络膜血管指数的对比研究及其在肥厚脉络膜谱疾病中的截断值的确定。
Jpn J Ophthalmol. 2021 Jul;65(4):482-491. doi: 10.1007/s10384-021-00829-5. Epub 2021 Mar 6.
8
Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography.厚脉络膜新生血管病变:光学相干断层扫描血管造影表现
Acta Ophthalmol. 2017 Jun;95(4):421-427. doi: 10.1111/aos.13221. Epub 2016 Sep 6.
9
[Research progress of pachychoroid disease spectrum].[厚脉络膜疾病谱的研究进展]
Zhonghua Yan Ke Za Zhi. 2023 Jan 11;59(1):68-72. doi: 10.3760/cma.j.cn112142-20220531-00272.
10
[Current understanding of pachychoroid spectrum diseases].[关于厚脉络膜谱系疾病的当前认识]
Vestn Oftalmol. 2019;135(5. Vyp. 2):293-298. doi: 10.17116/oftalma2019135052293.

引用本文的文献

1
[Bilateral, central serous chorioretinopathy under BRAF(B-rapidly accelerated fibrosarcoma)-/MEK (mitogen-activated protein kinase kinase)-inhibitor therapy in metastatic cutaneous melanoma.].[BRAF(B-快速进展性纤维肉瘤)/MEK(丝裂原活化蛋白激酶激酶)抑制剂治疗转移性皮肤黑色素瘤期间的双侧中心性浆液性脉络膜视网膜病变。]
Ophthalmologie. 2025 Jan;122(1):52-57. doi: 10.1007/s00347-024-02140-3. Epub 2024 Dec 6.
2
Subfoveal choroidal thickness increases after excimer laser-assisted penetrating keratoplasty but not after excimer laser-assisted deep anterior lamellar keratoplasty.准分子激光辅助穿透性角膜移植术后,中心凹下脉络膜厚度增加,但准分子激光辅助深层前板层角膜移植术后不会。
Sci Rep. 2024 Jul 3;14(1):15319. doi: 10.1038/s41598-024-66225-4.
3

本文引用的文献

1
Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5.年龄相关性黄斑变性中与进展为地图样萎缩相关的影像学特征:萎缩会议报告5分类
Ophthalmol Retina. 2021 Sep;5(9):855-867. doi: 10.1016/j.oret.2020.12.009. Epub 2020 Dec 22.
2
[Unilateral Irregularities in the Macular Pigment Epithelium in a 38-Year-Old Patient - "Acute Retinal Pigment Epitheliitis"].[一名38岁患者黄斑色素上皮的单侧异常——“急性视网膜色素上皮炎”]
Klin Monbl Augenheilkd. 2022 Mar;239(3):304-307. doi: 10.1055/a-1241-4521. Epub 2020 Oct 9.
3
Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept.
Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion.
脉络膜厚度可能是预测视网膜静脉阻塞后黄斑水肿对玻璃体内贝伐单抗治疗无反应的指标。
Sci Rep. 2023 Jan 9;13(1):451. doi: 10.1038/s41598-023-27753-7.
4
Early Stages of Age-Related Macular Degeneration: Racial/Ethnic Differences and Proposal of a New Classification Incorporating Emerging Concept of Choroidal Pathology.年龄相关性黄斑变性的早期阶段:种族/民族差异以及纳入脉络膜病理学新概念的新分类法建议
J Clin Med. 2022 Oct 25;11(21):6274. doi: 10.3390/jcm11216274.
脉络膜增厚型新生血管病变中雷珠单抗无应答:转换为阿柏西普的效果。
Sci Rep. 2020 May 21;10(1):8439. doi: 10.1038/s41598-020-65370-w.
4
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.依普利酮治疗活动期、未经治疗超过 4 个月的慢性中心性浆液性脉络膜视网膜病变(VICI)患者:一项随机、双盲、安慰剂对照试验。
Lancet. 2020 Jan 25;395(10220):294-303. doi: 10.1016/S0140-6736(19)32981-2.
5
The Pachychoroid Disease Spectrum-and the Need for a Uniform Classification System.肥厚脉络膜疾病谱——以及对统一分类系统的需求。
Ophthalmol Retina. 2019 Dec;3(12):1013-1015. doi: 10.1016/j.oret.2019.08.002.
6
[Nanosecond Laser Treatment in Chorioretinopathia Centralis Serosa without RPE Defects: A Retrospective Case Series].[无视网膜色素上皮缺陷的中心性浆液性脉络膜视网膜病变的纳秒激光治疗:一项回顾性病例系列研究]
Klin Monbl Augenheilkd. 2021 Jan;238(1):60-66. doi: 10.1055/a-0999-5542. Epub 2019 Oct 10.
7
[Acute macular neuroretinopathy in a 13-year-old female patient with focal choroidal excavation and pachychoroid disease].[一名患有局灶性脉络膜凹陷和厚脉络膜疾病的13岁女性患者的急性黄斑神经视网膜病变]
Ophthalmologe. 2020 Aug;117(8):791-797. doi: 10.1007/s00347-019-00974-w.
8
Predictive Factors of Response to Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous Chorioretinopathy.抗醛固酮受体拮抗剂治疗未缓解中心性浆液性脉络膜视网膜病变的反应预测因素。
Am J Ophthalmol. 2019 Feb;198:80-87. doi: 10.1016/j.ajo.2018.09.034. Epub 2018 Oct 9.
9
Clinical manifestations of pachychoroid may be secondary to pachysclera and increased scleral rigidity.脉络膜增厚的临床表现可能继发于巩膜肥厚和巩膜刚性增加。
Med Hypotheses. 2018 Apr;113:72-73. doi: 10.1016/j.mehy.2018.02.024. Epub 2018 Feb 24.
10
Changes in Choroidal Thickness After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy.脉络膜厚度在特发性脉络膜新生血管中的变化。
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):1119-1124. doi: 10.1167/iovs.17-22144.